Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Occupational Therapy Treatment to Improve Upper Extremity Function in Individuals with Early Systemic Sclerosis: A Pilot Study

View through CrossRef
ObjectiveTo determine the feasibility and preliminary effects of occupational therapy to improve upper extremity function in patients with early systemic sclerosis (SSc; scleroderma) who have upper extremity contractures.MethodsA single‐group pilot clinical rehabilitation trial was conducted at the University of Michigan Scleroderma Center. Patients with SSc and ≥1 upper extremity contracture (n = 21) participated in a total of 8 weekly in‐person occupational therapy sessions. The therapy consisted of thermal modalities, tissue mobilization, and upper extremity mobility exercises. The participants were instructed to perform upper extremity exercises at home between sessions. Feasibility was measured by the percent enrollment as well as session attendance and session duration. The primary outcome measure was the Shortened Disabilities of the Arm, Shoulder and Hand measure (QuickDASH); secondary and exploratory outcomes included the Patient‐Reported Outcomes Measurement Information System (PROMIS) physical function measures; objective measures of upper extremity mobility, strength, and coordination; and skin thickening. Linear mixed models were used to determine the effects of treatment on the primary and secondary outcomes.ResultsFifty percent of potentially eligible subjects (24 of 48) were interested in participating. Twenty‐one (88%) of the 24 subjects were enrolled, and 19 (91%) of these 21 subjects completed all sessions. The mean ± SD age of the participants was 47.9 ± 16.1 years; 100% had diffuse SSc, and the mean disease duration was 3.1 years. At 8 weeks, participants had statistically significant improvement in the QuickDASH and PROMIS physical function measure (P = 0.0012 and P = 0.004, respectively). Approximately one‐half of participants in the sample achieved improvement in the QuickDASH and PROMIS measure that exceeded minimally important differences.ConclusionIn‐person treatment sessions were feasible in the patients with SSc and resulted in statistically significant and clinically meaningful improvements in upper extremity and physical function. In future studies, the effects of SSc should be compared with those in a control condition, and the durability of treatment effects should be examined.
Title: Occupational Therapy Treatment to Improve Upper Extremity Function in Individuals with Early Systemic Sclerosis: A Pilot Study
Description:
ObjectiveTo determine the feasibility and preliminary effects of occupational therapy to improve upper extremity function in patients with early systemic sclerosis (SSc; scleroderma) who have upper extremity contractures.
MethodsA single‐group pilot clinical rehabilitation trial was conducted at the University of Michigan Scleroderma Center.
Patients with SSc and ≥1 upper extremity contracture (n = 21) participated in a total of 8 weekly in‐person occupational therapy sessions.
The therapy consisted of thermal modalities, tissue mobilization, and upper extremity mobility exercises.
The participants were instructed to perform upper extremity exercises at home between sessions.
Feasibility was measured by the percent enrollment as well as session attendance and session duration.
The primary outcome measure was the Shortened Disabilities of the Arm, Shoulder and Hand measure (QuickDASH); secondary and exploratory outcomes included the Patient‐Reported Outcomes Measurement Information System (PROMIS) physical function measures; objective measures of upper extremity mobility, strength, and coordination; and skin thickening.
Linear mixed models were used to determine the effects of treatment on the primary and secondary outcomes.
ResultsFifty percent of potentially eligible subjects (24 of 48) were interested in participating.
Twenty‐one (88%) of the 24 subjects were enrolled, and 19 (91%) of these 21 subjects completed all sessions.
The mean ± SD age of the participants was 47.
9 ± 16.
1 years; 100% had diffuse SSc, and the mean disease duration was 3.
1 years.
At 8 weeks, participants had statistically significant improvement in the QuickDASH and PROMIS physical function measure (P = 0.
0012 and P = 0.
004, respectively).
Approximately one‐half of participants in the sample achieved improvement in the QuickDASH and PROMIS measure that exceeded minimally important differences.
ConclusionIn‐person treatment sessions were feasible in the patients with SSc and resulted in statistically significant and clinically meaningful improvements in upper extremity and physical function.
In future studies, the effects of SSc should be compared with those in a control condition, and the durability of treatment effects should be examined.

Related Results

Advances in Upper Extremity Scleroderma Wound Care
Advances in Upper Extremity Scleroderma Wound Care
ABSTRACTGENERAL PURPOSE:To provide information about the pathophysiology, diagnosis, and treatment options for systemic sclerosis.TARGET AUDIENCE:This continuing education activity...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
THE ROLE OF PHYSICAL EXERCISE IN REDUCING INFLAMMATION IN PATIENTS WITH SYSTEMIC SCLEROSIS
THE ROLE OF PHYSICAL EXERCISE IN REDUCING INFLAMMATION IN PATIENTS WITH SYSTEMIC SCLEROSIS
Introduction and Aim: Systemic sclerosis (SSc) is a chronic, progressive disease that leads to multi-organ failure. In its pathogenesis, inflammation plays a significant role, part...
The Occupational Therapy Profession in Saudi Arabia
The Occupational Therapy Profession in Saudi Arabia
Objective. To provide an evidence‐based description of how the occupational therapy profession operates in Saudi Arabia. Methods. A case study methodology set out an evidence‐based...
Pembrolizumab and Sarcoma: A meta-analysis
Pembrolizumab and Sarcoma: A meta-analysis
Abstract Introduction: Pembrolizumab is a monoclonal antibody that promotes antitumor immunity. This study presents a systematic review and meta-analysis of the efficacy and safety...

Back to Top